Skip to content

Drug interactions

Apalutamide + Lenvatinib

Severity: Minor

Apalutamide and Lenvatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenvatinib is a minor BCRP and P-gp substrate and is partly cleared by CYP3A4. Apalutamide might reduce lenvatinib exposure, but the clinical effect is likely small.

What this interaction means in plain words

Apalutamide and Lenvatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Apalutamide belongs to Endocrine; Lenvatinib belongs to Oncology.

Evidence level: Low

Why it happens

Apalutamide weakly induces BCRP, P-gp and CYP3A4, which may lower lenvatinib exposure.

What to do

No dose change is required. Monitor tumor response and blood pressure.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Lenvatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Apalutamide with Lenvatinib?

MediHelp rates the interaction as minor. Apalutamide and Lenvatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lenvatinib is a minor BCRP and P-gp substrate and is partly cleared by CYP3A4. Apalutamide might reduce lenvatinib exposure, but the clinical effect is likely small.

How serious is the interaction between Apalutamide and Lenvatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is required. Monitor tumor response and blood pressure.

What other medicines interact with Apalutamide?

MediHelp also lists interactions of Apalutamide with, for example, Cabotegravir, Cobicistat, Doravirine. The full list is on the Apalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in